What’s This Research About?
Anxiety disorders are the most common type of mental health disorder, impacting an estimated 301 million individuals around the world. Generalized anxiety disorder, social anxiety disorder, and panic disorder are among the anxiety disorders studied.
Effective treatment options for anxiety disorders include medication and cognitive-behavioral therapy among others. However, many patients opt not to take medications, do not respond to them, or cannot obtain treatment due to a lack of access. Additionally, seeking help for mental health conditions, unfortunately, carries a stigma that many want to avoid.
Mindfulness interventions are increasing in popularity and may provide a viable alternative treatment or co-treatment option. This study examines the effectiveness of mindfulness-based stress reduction (MBSR) compared to escitalopram (generic Lexapro) in reducing anxiety levels.
TITLE: Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults with Anxiety Disorders
PUBLICATION: JAMA Psychiatry
DATE: November, 2022
AUTHORS: Elizabeth A. Hoge, Eric Bui, Mihriye Mete, Mary Ann Dutton, Amanda W. Baker, and Naomi M. Simon
Anxiety disorders: These mental health conditions are characterized by feelings of worry, fear, and intrusive thoughts. They affect an estimated 301 million people around the world.
Escitalopram: The generic form of the antidepressant medication Lexapro. It is a selective serotonin reuptake inhibitor (SSRI), which acts to increase serotonin at synapses in the brain.
Mindfulness-based stress reduction (MBSR): This eight-week evidence-based program was created by Professor Jon Kabat-Zinn at the University of Massachusetts to assist people in decreasing their symptoms of anxiety, depression, and pain. It uses a combination of meditation, body awareness, and yoga to bring about non-judgmental acceptance.
Register
